Business Standard

Dr Reddy's surges 9% on Betapharm buyout

DALAL STREET SPIKES

Image

Our Markets Bureau Mumbai
Dr Reddy's shot up by 9.38 per cent to end at Rs 1281.95, after touching a 52- week high of Rs 1,295 in the intra-day trading. The stock witnessed volumes of 4 lakh shares.
 
The announcement that the company has acquired 100 per cent stake in Betapharm, the fourth-largest generic pharmaceuticals company in Germany for $480 million in cash boosted the stock.
 
The acquisition will enable the company to build a strategic presence in European markets. The scrip had surged since late January 2006 on the back of strong Q3 results.

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 17 2006 | 12:00 AM IST

Explore News